- Home
- PBYI vs MMD Comparison
PBYI vs MMD Comparison
Compare PBYI & MMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- MMD
- Stock Information
- Founded
- PBYI 2010
- MMD 2012
- Country
- PBYI United States
- MMD United States
- Employees
- PBYI N/A
- MMD N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- MMD Investment Managers
- Sector
- PBYI Health Care
- MMD Finance
- Exchange
- PBYI Nasdaq
- MMD Nasdaq
- Market Cap
- PBYI 263.4M
- MMD 284.7M
- IPO Year
- PBYI N/A
- MMD N/A
- Fundamental
- Price
- PBYI $4.95
- MMD $15.12
- Analyst Decision
- PBYI Strong Buy
- MMD
- Analyst Count
- PBYI 1
- MMD 0
- Target Price
- PBYI $7.00
- MMD N/A
- AVG Volume (30 Days)
- PBYI 418.9K
- MMD 74.7K
- Earning Date
- PBYI 11-06-2025
- MMD 01-01-0001
- Dividend Yield
- PBYI N/A
- MMD 4.88%
- EPS Growth
- PBYI 434.29
- MMD N/A
- EPS
- PBYI 0.97
- MMD N/A
- Revenue
- PBYI $238,062,000.00
- MMD N/A
- Revenue This Year
- PBYI N/A
- MMD N/A
- Revenue Next Year
- PBYI N/A
- MMD N/A
- P/E Ratio
- PBYI $5.08
- MMD N/A
- Revenue Growth
- PBYI 8.63
- MMD N/A
- 52 Week Low
- PBYI $2.32
- MMD $14.30
- 52 Week High
- PBYI $6.07
- MMD $17.67
- Technical
- Relative Strength Index (RSI)
- PBYI 45.94
- MMD 52.54
- Support Level
- PBYI $5.14
- MMD $15.03
- Resistance Level
- PBYI $5.52
- MMD $15.19
- Average True Range (ATR)
- PBYI 0.25
- MMD 0.11
- MACD
- PBYI -0.06
- MMD -0.01
- Stochastic Oscillator
- PBYI 17.82
- MMD 60.87
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
NYLI MacKay DefinedTerm Muni Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.